Home › Trial NCT01813474
Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
- Trial IDNCT01813474
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAstraZeneca
- Enrollment23
- Start date2013-03-25
- ConditionsCancer · Advanced Solid Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.